U.S. markets closed

DermTech, Inc. (DMTK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
66.73-4.43 (-6.23%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close71.16
Bid65.50 x 800
Ask66.73 x 900
Day's Range65.10 - 73.68
52 Week Range8.69 - 84.49
Avg. Volume1,240,677
Market Cap1.696B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.34
Earnings DateMar 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • 3 Unstoppable Growth Stocks to Buy Right Now
    Motley Fool

    3 Unstoppable Growth Stocks to Buy Right Now

    Chuck Norris has... some kind of limitation, I'm sure. Thirty-five states have legalized medical cannabis. Cresco Labs (OTC: CRLBF) ranks as one of the largest multistate cannabis operators and is profiting tremendously from the cannabis boom.

  • Motley Fool

    Why DermTech Stock Is a Buy Right Now

    DermTech (NASDAQ: DMTK) is one of several companies that have gone public via a merger with a special purpose acquisition company (SPAC). In this Motley Fool Live video recorded on Feb. 17, 2021, Fool.com contributors Keith Speights and Brian Orelli talk about why DermTech is a good stock to buy right now. Aaron asks thoughts on DermTech; the ticker there is DMTK.

  • DermTech Abstracts Selected to Present at Society of Investigative Dermatology Virtual Meeting
    Business Wire

    DermTech Abstracts Selected to Present at Society of Investigative Dermatology Virtual Meeting

    DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that four of its abstracts were selected by the Society for Investigative Dermatology ("SID") for presentation at the SID Virtual Meeting, taking place May 3-8, 2021. The SID is committed to the advancement of skin health and disease through education, advocacy and scholarly exchange of scientific information. In addition to virtual sessions, the abstracts will be published in a forthcoming supplemental issue of the Journal of Investigative Dermatology.